id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-3293-0010,FDA,FDA-2019-E-3293,Certificate Extending Patent Term,Other,Certificate Extending Patent Term,2024-07-31T04:00:00Z,2024,7,2024-07-31T04:00:00Z,,2024-07-31T12:13:26Z,,0,0,0900006486605ee6
FDA-2019-E-3293-0009,FDA,FDA-2019-E-3293,Notice of Final Determination and Requirement for Election Letter from U.S. Patent and Trademark Office to Kilpatrick Townsend & Stockton LLP – West Coast,Other,Letter(s),2024-02-28T05:00:00Z,2024,2,2024-02-28T05:00:00Z,,2024-02-28T20:50:16Z,,0,0,090000648641dc9d
FDA-2019-E-3293-0008,FDA,FDA-2019-E-3293,"Requirement for Information from U. S. Patent and Trademark Office to Wenderoth, Lind & Ponack. L.L.P.",Other,Letter(s),2024-02-21T05:00:00Z,2024,2,2024-02-21T05:00:00Z,,2024-02-21T21:45:41Z,,0,0,09000064863e858f
FDA-2019-E-3293-0007,FDA,FDA-2019-E-3293,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2023-11-15T05:00:00Z,2023,11,2023-11-15T05:00:00Z,,2023-11-15T18:55:15Z,,0,0,090000648627d24a
FDA-2019-E-3293-0006,FDA,FDA-2019-E-3293,Determination of Regulatory Review Period for Purposes of Patent Extension; MULPLETA,Notice,Determinations,2023-03-22T04:00:00Z,2023,3,2023-03-22T04:00:00Z,2023-05-23T03:59:59Z,2023-03-22T14:59:21Z,2023-05799,0,0,090000648582325d
FDA-2019-E-3293-0005,FDA,FDA-2019-E-3293,Letter to U.S. Patent and Trademark Office from FDA CDER,Other,Letter(s),2023-03-09T05:00:00Z,2023,3,2023-03-09T05:00:00Z,,2023-03-09T18:15:52Z,,0,0,0900006485783a34
FDA-2019-E-3293-0004,FDA,FDA-2019-E-3293,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T21:24:45Z,,0,0,090000648555f874
FDA-2019-E-3293-0003,FDA,FDA-2019-E-3293,Letter to U.S. Patent and Trademark Office from FDA CDER,Other,Letter(s),2019-10-29T04:00:00Z,2019,10,2019-10-29T04:00:00Z,,2019-10-29T20:29:07Z,,0,0,0900006484106cf0
FDA-2019-E-3293-0002,FDA,FDA-2019-E-3293,"Patent Extension Application from Wenderoth Lind & Ponack LLP (on behalf of Shionogi & Co., Ltd.)",Other,Application,2019-07-09T04:00:00Z,2019,7,2019-07-09T04:00:00Z,,2019-07-09T13:55:20Z,,0,0,0900006483d6dfd3
FDA-2019-E-3293-0001,FDA,FDA-2019-E-3293,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2019-07-09T04:00:00Z,2019,7,2019-07-09T04:00:00Z,,2019-07-09T13:50:59Z,,0,0,0900006483d6dfd2